image
Conservation

Compilation of herbal plants (description, geographical distribution, taxonomy, line drawings), biodiversity and herbarium.

Read More
image
Research & Publication

Description of herbal and T&CM research, searchable publication and process from medicinal plant discovery to clinical trial in producing a high-quality registered herbal drug.

Read More
 
Traditional & Complementary Medicine (T&CM)

 

Definition and description of therapies, policy, training and education, research in the practise of (T&CM) and integrated medicine system.           

Read More

 

News Update

Announcement & Advertisement

Forthcoming Events

4th International Conference on Natural Products and Medicinal Plants Research

From Fri, 25. September 2020 Until Sat, 26. September 2020

15th International Conference on Frontiers in Alternative & Traditional Medicine

From Fri, 25. September 2020 Until Sat, 26. September 2020

International Congress on Drug Delivery

From Mon, 5. October 2020 Until Tue, 6. October 2020

Global Pharmaceutical and Pharma Industry Conference

From Mon, 12. October 2020 Until Tue, 13. October 2020

14th International Conference on Pharmaceutics and Drug Safety

From Wed, 21. October 2020 Until Thu, 22. October 2020

Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study

Author

Walker AF, Middleton RW, Petrowicz O

Date

2/2001

Journal

Phytother Res

Abstract

Irritable bowel syndrome (IBS) is a problem reported to affect 22% of the general population. It is characterized by abdominal pain and altered bowel habit, but has so far defied elucidation of its pathogenesis and proved difficult to treat. There is a growing body of evidence which indicates therapeutic properties for artichoke leaf extract (ALE). Dyspepsia is the condition for which the herb is specifically indicated, but the symptom overlap between dyspeptic syndrome and IBS has given rise to the notion that ALE may have potential for treating IBS as well. A sub-group of patients with IBS symptoms was therefore identified from a sample of individuals with dyspeptic syndrome who were being monitored in a post-marketing surveillance study of ALE for 6 weeks. Analysis of the data from the IBS sub-group revealed significant reductions in the severity of symptoms and favourable evaluations of overall effectiveness by both physicians and patients. Furthermore, 96% of patients rated ALE as better than or at least equal to previous therapies administered for their symptoms, and the tolerability of ALE was very good. These results provide support for the notion that ALE has potential value in relieving IBS symptoms and suggest that a controlled trial is justified. Copyright 2001 John Wiley & Sons, Ltd.

Explore Further

Consumer Data

Consumer data including medicinal herbs, dietary supplement monographs, health condition monographs and interactions and depletions.                                    

Read More
Professional Data

Professional data organized into medicinal herbs, dietary supplement monographs, health condition monographs, T&CM herbs, formulas, health conditions, interactions and depletions.

Read More
International Data

We offer International linkages to provide extensive content pertaining to many facets of T&CM as well as Integrated Medicine. Please register for access.    

Read More